SonoVue Guided Prostate Biopsy

Update Il y a 2 ans
Reference: NCT00911027


This is a phase III European multicenter, open label, prospective study to assess the diagnostic accuracy of the use of SonoVue contrast agent to guide prostate biopsies in comparison with the current practice of ultrasound guided systematic biopsy. The trial will involve 15-20 European Centers.

Inclusion criteria

  • Prostate cancer